Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Priority Income Fund D Pref PRIF-D 25. avr 2025 23.85 0.00   
 Priority Income Fund F Pref PRIF-F 25. avr 2025 24.67 -0.08   
 Priority Income Fund I Pref PRIF-I 25. avr 2025 23.66 +1.16   
 Priority Income Fund J Pref PRIF-J 25. avr 2025 22.93 -0.04   
 Priority Income Fund Pref PRIF-H 25. avr 2025 25.02 0.00   
 Priority Technology PRTH 25. avr 2025 7.35 0.00   
 Privia Health Group PRVA 25. avr 2025 23.17 -1.24   
 Pro-Dex PDEX 25. avr 2025 64.89 -3.03   
 ProAssurance PRA 25. avr 2025 23.10 -0.04   
 Procept BioRobotics PRCT 25. avr 2025 52.49 -0.13   
 Processa Pharmaceuticals PCSA 25. avr 2025 0.24 -0.71   
 Procore Technologies PCOR 25. avr 2025 63.74 +1.19   
 Procter & Gamble PG 25. avr 2025 161.02 +0.93   
 Professional Diversity Network IPDN 25. avr 2025 1.41 +8.46   
 Proficient Auto Logistics PAL 25. avr 2025 9.16 +0.44   
 Profound Medical PROF 25. avr 2025 4.76 +0.95   
 ProFrac A ACDC 25. avr 2025 4.77 +2.36   
 PROG PRG 25. avr 2025 25.71 +3.00   
 Progress Software PRGS 25. avr 2025 59.11 +0.07   
 Progressive PGR 25. avr 2025 265.01 -0.07   
 Progyny PGNY 25. avr 2025 22.76 -0.61   
 ProKidney PROK 25. avr 2025 1.02 +3.01   
 Prologis PLD 25. avr 2025 102.24 -1.08   
 ProMIS Neurosciences PMN 25. avr 2025 0.59 +4.88   
 ProPetro PUMP 25. avr 2025 5.32 +2.31   
 ProPhase Labs PRPH 25. avr 2025 0.37 +10.05   
 ProQR Therapeutics PRQR 25. avr 2025 1.43 -7.14   
 PROS PRO 25. avr 2025 17.88 +2.76   
 ProShares Bitcoin Strategy ETF BITO 25. avr 2025 20.75 +1.77   
 Proshares Ultra FTSE Europe UPV 25. avr 2025 68.57 +0.75   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.